Accueil   Diary - News   All news Kigabeq® launch in Germany

Kigabeq® launch in Germany



ORPHELIA Pharma and DESITIN GmbH announce the launch of Kigabeq® in Germany


Paris/Lyon and Hamburg, July 16, 2019 – ORPHELIA Pharma, a French biopharmaceutical company dedicated to the development and marketing of pediatric drugs in the fields of oncology and neurology, announces today that it has entered into a license and distribution agreement with the epilepsy specialist Desitin GmbH to market Kigabeq® in Germany.


Read the press release